Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.8 GBX | 0.00% | -6.91% | +41.44% |
01/05 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
01/05 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- POLB Stock
- Revisions Poolbeg Pharma PLC